Gerit Theil
Impact in
- Nephrology top 5%
- Chronic Kidney Disease and Diabetes
- Dialysis and Renal Disease Management
-
- Cancer Genomics and Diagnostics
- MicroRNA in disease regulation
Papers in
-
- Prostate Cancer Treatment and Research 8
- Renal cell carcinoma treatment 4
- Renal and Vascular Pathologies 3
- Oncology 16
- Cancer Cells and Metastasis 10
- Co-authors
- Edward L. Alpen (1 shared paper)Paul D. Doolan (1 shared paper)Paolo Fornara (28 shared papers)Kersten Fischer (11 shared papers)Ekkehard Weber (3 shared papers)Joanna Białek (10 shared papers)Klaus Lücke (3 shared papers)Nasreldin Mohammed (4 shared papers)
- Journals
- World Journal of Urology (5 papers)Life (3 papers)Cancer Research (2 papers)The American Journal of the Medical Sciences (1 paper)Journal of Oncology (1 paper)
- Partner nations
- GermanyUnited StatesMalaysia
In The Last Decade
Gerit Theil
39 papers receiving 716 citations
Peers
Comparison fields: 5 of 108
- Nephrology 145
- Cancer Research 158
- Urology 67
- Pulmonary and Respiratory Medicine 203
- Rheumatology 88
Countries citing papers authored by Gerit Theil
This map shows the geographic impact of Gerit Theil's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gerit Theil with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gerit Theil more than expected).
Fields of papers citing papers by Gerit Theil
This network shows the impact of papers produced by Gerit Theil. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gerit Theil. The network helps show where Gerit Theil may publish in the future.
Co-authors
The 25 scholars most cited alongside Gerit Theil, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 39 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1962 | 293 | |
| 2 | 2004 | 57 | |
| 3 | 2016 | 51 | |
| 4 | 2015 | 45 | |
| 5 | 2017 | 40 | |
| 6 | 2016 | 35 | |
| 7 | 2012 | 33 | |
| 8 | 2017 | 25 | |
| 9 | Serum amyloid A: a biomarker for renal cancer. | 2012 | 24 |
| 10 | 2021 | 19 | |
| 11 | 2013 | 15 | |
| 12 | 2024 | 14 | |
| 13 | 2018 | 12 | |
| 14 | 2018 | 12 | |
| 15 | 2021 | 10 | |
| 16 | 1970 | 9 | |
| 17 | 2021 | 8 | |
| 18 | 1963 | 8 | |
| 19 | 2020 | 8 | |
| 20 | 2022 | 7 |
About Gerit Theil
Gerit Theil is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Molecular Biology, Cancer Research and Surgery, having authored 39 papers that have together received 776 indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (10 papers), Cancer Genomics and Diagnostics (8 papers), Prostate Cancer Treatment and Research (8 papers), Renal cell carcinoma treatment (4 papers), Renal and related cancers (4 papers), Renal and Vascular Pathologies (3 papers), MicroRNA in disease regulation (3 papers) and Cancer-related molecular mechanisms research (3 papers). The work is most often cited by research in Nephrology (145 citations), Cancer Research (158 citations), Urology (67 citations), Pulmonary and Respiratory Medicine (203 citations) and Rheumatology (88 citations). Gerit Theil has collaborated with scholars based in Germany, United States and Malaysia. Frequent co-authors include Edward L. Alpen, Paul D. Doolan, Paolo Fornara, Kersten Fischer, Ekkehard Weber, Joanna Białek, Klaus Lücke, Nasreldin Mohammed, M. Raschid Hoda and Helge Täubert. Their work appears in journals such as World Journal of Urology, Life, Cancer Research, The American Journal of the Medical Sciences and Journal of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.